Stay updated on Pembrolizumab in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Pancreatic Cancer Clinical Trial page.
Latest updates to the Pembrolizumab in Pancreatic Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page; no study content was altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check28 days agoChange DetectedRemoved the government funding/operating status notice banner from the page, which previously warned users about potential delays and where to check operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check42 days agoChange DetectedThe screenshots show essentially the same study details page with no substantial edits to core content such as eligibility criteria, interventions, or outcomes; only minor UI/formatting differences. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check71 days agoChange DetectedAdded a government-funding notice and updated the version to v3.2.0, while removing the old v3.1.0 version tag.SummaryDifference5%
- Check78 days agoChange DetectedUpdated to Revision: v3.1.0 with expanded contact emails/phone numbers; removed obsolete revision v3.0.2. No changes detected to pricing, stock, or time slots.SummaryDifference0.1%
- Check92 days agoChange DetectedUpdated Revision from v3.0.1 to v3.0.2; removed the 'Back to Top' element. No other substantive changes detected.SummaryDifference0.3%
Stay in the know with updates to Pembrolizumab in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Pancreatic Cancer Clinical Trial page.